nitroglycerin has been researched along with Diabetic Retinopathy in 3 studies
Nitroglycerin: A volatile vasodilator which relieves ANGINA PECTORIS by stimulating GUANYLATE CYCLASE and lowering cytosolic calcium. It is also sometimes used for TOCOLYSIS and explosives.
nitroglycerol : A nitrate ester that is glycerol in which nitro group(s) replace the hydrogen(s) attached to one or more of the hydroxy groups.
nitroglycerin : A nitroglycerol that is glycerol in which the hydrogen atoms of all three hydroxy groups are replaced by nitro groups. It acts as a prodrug, releasing nitric oxide to open blood vessels and so alleviate heart pain.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with type 1 diabetes mellitus featuring no or mild nonproliferative diabetic retinopathy and 20 healthy, age-matched subjects were included in this study." | 2.74 | Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes. ( Garhofer, G; Karl, K; Pemp, B; Resch, H; Schmetterer, L; Weigert, G; Wolzt, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pemp, B | 1 |
| Garhofer, G | 1 |
| Weigert, G | 1 |
| Karl, K | 1 |
| Resch, H | 1 |
| Wolzt, M | 1 |
| Schmetterer, L | 1 |
| Frauchiger, B | 1 |
| Nussbaumer, P | 1 |
| Hugentobler, M | 1 |
| Staub, D | 1 |
| Dogra, G | 1 |
| Rich, L | 1 |
| Stanton, K | 1 |
| Watts, GF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Correlation of Flicker Induced and Flow Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy Volunteers[NCT00432029] | 80 participants (Actual) | Interventional | 2006-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for nitroglycerin and Diabetic Retinopathy
| Article | Year |
|---|---|
Reduced retinal vessel response to flicker stimulation but not to exogenous nitric oxide in type 1 diabetes.
Topics: Adult; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; Glyca | 2009 |
2 other studies available for nitroglycerin and Diabetic Retinopathy
| Article | Year |
|---|---|
Duplex sonographic registration of age and diabetes-related loss of renal vasodilatory response to nitroglycerine.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arterioles; Diabetes Mellitus, Type 1; Diabetes Mellitus, Typ | 2000 |
Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria.
Topics: Adolescent; Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Blood | 2001 |